An efficient antiviral response induces the recruitment of RSV-specific CD4+ and CD8+ T cells to the infection site by the CXCL9 and CXCL10 chemokines, which are induced by IFNs and the chemokine receptor CXCR3. The gene discussed is CXCL10; the disease is infection.